Rosiglitazone reduces the in vitro and in vivo growth of HCC cell lines through a PPARgamma-independent inhibition of Ruvbl-1

被引：0
|
作者：
Mello, Tommaso [1 ,2 ]
Tarocchi, Mirko [1 ]
Buccoliero, Francesca [1 ]
Ceni, Elisabetta [1 ]
Polvani, Simone [1 ]
Milani, Stefano [1 ,2 ]
Galli, Andrea [1 ,2 ]
机构：
[1] Univ Florence, Florence, Italy
[2] Careggi Univ Hosp, SOD Gastroenterol 1, Florence, Italy
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1257
引用
收藏
页码：789A / 789A
页数：1
相关论文
共 50 条
  • [1] ROSIGLITAZONE INHIBITS HEPATOCELLULAR CANCER CELL GROWTH AND DOWN-REGULATES RUVBL-1: EVIDENCES OF A PPARgamma-INDEPENDENT MECHANISM OF CELL GROWTH INHIBITION
    Mello, T.
    Buccoliero, F.
    Tarocchi, M.
    Foresta, V.
    Cioni, L.
    Ottanelli, B.
    Polvani, S.
    Ceni, E.
    Milani, S.
    Surrenti, C.
    Galli, A.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S23 - S23
  • [2] Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition
    Nicolas Charette
    Christine De Saeger
    Valérie Lannoy
    Yves Horsmans
    Isabelle Leclercq
    Peter Stärkel
    Molecular Cancer, 9
  • [3] Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition
    Charette, Nicolas
    De Saeger, Christine
    Lannoy, Valerie
    Horsmans, Yves
    Leclercq, Isabelle
    Starkel, Peter
    MOLECULAR CANCER, 2010, 9
  • [4] Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo
    Wei, Gang
    Wang, Meifang
    Hyslop, Terry
    Wang, Ziqiu
    Carr, Brian I.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (12) : 2949 - 2958
  • [5] In vitro and in vivo growth inhibition and G1 arrest in human cancer cell lines by diaminophenyladamantane derivatives
    Wang, JJ
    Chen, YC
    Chi, CW
    Huang, KT
    Chern, YT
    ANTI-CANCER DRUGS, 2004, 15 (07) : 697 - 705
  • [6] Antisense inhibition of methylenetetrahydrofolate reductase reduces cancer cell survival in vitro and tumor growth in vivo
    Stankova, A
    Shang, JJ
    Rozen, R
    CLINICAL CANCER RESEARCH, 2005, 11 (05) : 2047 - 2052
  • [7] Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo
    Tummler, Conny
    Snapkov, Igor
    Wickstrom, Malin
    Moens, Ugo
    Ljungblad, Linda
    Elfman, Lotta Helena Maria
    Winberg, Jan-Olof
    Kogner, Per
    Johnsen, John Inge
    Sveinbjornsson, Baldur
    ONCOTARGET, 2017, 8 (56) : 95135 - 95151
  • [8] Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch
    Floyd, Desiree H.
    Kefas, Benjamin
    Seleverstov, Oleksandr
    Mykhaylyk, Olga
    Dominguez, Charli
    Comeau, Laurey
    Plank, Christian
    Purow, Benjamin
    NEURO-ONCOLOGY, 2012, 14 (10) : 1215 - 1226
  • [9] Targeted inhibition of Hedgehog (HH) signal transduction in rhabdomyosarcoma (RMS) reduces cell survival in vitro and tumor growth in vivo
    Yoon, Joon Won
    Chandler, Christopher
    Lamm, Marilyn
    Leong, King-Fu
    Iannaccone, Stephen
    Taborn, Gregory
    Iannaccone, Philip
    Walterhouse, David
    CANCER RESEARCH, 2015, 75
  • [10] Vivo and in vitro effect and mechanisms of cyclooxygenase-2 (COX-2)-independent growth inhibition of human hepatocellular carcinoma (HCC) cells by celecoxib
    Cui, W
    Yu, CH
    Tang, ZY
    Hu, KQ
    HEPATOLOGY, 2005, 42 (04) : 302A - 302A
12345